INCY
Incyte CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #588
- Final score
- 47.04
- Years on list
- 6
↗ Climbed 103 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- INCY· Incyte Corporation
- NTRA· Natera, Inc.
- VRTX· Vertex Pharmaceuticals Incorporated
Figure 01 · Side-by-side summary
The headline numbers
NTRA
Natera, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #542
- Final score
- 48.88
- Years on list
- 4
↗ Climbed 439 since 2022
VRTX
Vertex Pharmaceuticals IncorporatedPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #618
- Final score
- 45.58
- Years on list
- 6
↘ Down 130 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | INCY | NTRA | VRTX |
|---|---|---|---|
| Climate Change | 64.3 | 57.1 | 57.2 |
| Employee Relations | 60.5 | 40.3 | 48.3 |
| Environment | 42.0 | 55.8 | 40.0 |
| Stakeholders & Society | 34.2 | 35.1 | 42.4 |
| Human Rights | 9.9 | 51.9 | 34.2 |
| Governance | 49.4 | 45.3 | 39.2 |
| Performance Rating | 48.8 | 61.7 | 50.6 |